T2	Participants 241 271	locally advanced rectal cancer
T4	Participants 451 502	Patients (N = 207) with nonresectable rectal cancer
T1	Participants 87 114	nonresectable rectal cancer
T3	Participants 1009 1026	Norway and Sweden
T5	Participants 1864 1894	locally advanced rectal cancer
